Searchable abstracts of presentations at key conferences in endocrinology

ea0005p184 | Neuroendocrinology and Behaviour | BES2003

Differential effects of the route of testosterone administration on GH sensitivity and bone mineral density in hypopituitarism

Brooke A , Carroll P , Walker D , Besser G , Monson J

The route of oestrogen replacement has an important influence on growth hormone (GH) sensitivity, but it remains unclear whether the route of testosterone treatment in hypopituitarism influences the response to GH replacement. We have compared IGF-I levels, body composition and BMD in hypopituitary male patients with severe GH-deficiency receiving either oral testosterone undecanoate (T.U.)(80-160 milligrams per day) or intramuscular testosterone (I.M.) (250-500 milligrams per...

ea0005p200 | Reproduction | BES2003

Biological variation of free androgen index and bioavailable testosterone in PCOS: Implications for estimation of hyperandrogenaemia

Jayagopal V , Diver M , Kilpatrick E , Jennings P , Atkin S

Objective: Bioavailable testosterone (BioT) is measured directly by bioassay or estimated by calculating the free androgen index (FAI) and reflects hyperandrogenaemia more accurately than measurement of total testosterone in plasma. A comparison of the biological variation of FAI and measured BioT was undertaken to determine the relative suitability of these estimates in PCOS.Method: The biological variation of BioT and FAI was assessed in 12 PCOS patients (median age 28yr...

ea0005p240 | Steroids | BES2003

Is the cortisol day curve a useful tool?

Evans P , Wilkin T , Jeffery J , Williams R , Flanagan D

The cortisol day curve has been advocated in the assessment of glucocorticoid replacement therapy in adrenal failure but remains controversial.Objective: To determine the validity of this test within our practice.Method: A retrospective analysis using endocrine laboratory dataset.Results: 102 inpatient cortisol day curves from 76 patients were analysed. The serum cortisol was checked at 5 time points (pre and 1 hour post morning dose, before midday dose, pre and po...

ea0003oc12 | Endocrine Neoplasia | BES2002

Ghrelin inhibits proliferation of breast cell lines acting via the growth hormone secretagogue receptor (GHS-R)

Taylor J , Hughes B , Sheppard M , Stewart P , Toogood A

Ghrelin, the natural ligand for the GHS-R, modulates proliferation in cell lines derived from malignant breast tissue. It has been suggested that this action is independent of the GHS-R. We have previously demonstrated that MCF7 cells expressed ghrelin but not GHS-R mRNA and MDA-MB231 cells expressed GHS-R but not ghrelin mRNA. To determine whether ghrelin modulates proliferation in MCF7 and MDA-MB231 cells we performed proliferation assays treating with saline, 1 and 10nM ghr...

ea0030p51 | (1) | BSPED2012

Growth and glucose homeostasis after 2 years in children with inflammatory bowel disease receiving recombinant GH therapy for growth retardation

Towati Mabrouka A L , Wong S C , Galloway P J , Hassan K , Russell R K , McGrogan P , Ahmed S F

Background: A recent RCT of rhGH in IBD over 6 months showed that improvement in linear growth was associated with a reduction in insulin sensitivity.Objectives: To investigate the effects of prolonged rhGH on growth and glucose homeostasis in children with IBD.Patients and methods: Eleven children (10CD/1UC) (9 m) with a median age of 14.7 years (range, 8.9, 16.2) who received rhGH (0.067 mg/kg per day) as part a 6-month RCT were ...

ea0036P73 | (1) | BSPED2014

GH deficiency contributes to short stature in children with chromosome 18 rearrangements

Prasad Rathi , Crowne Elizabeth C , Burren Christine P

Introduction: Chromosome 18 rearrangements are postulated to be associated with short stature, of uncertain pathophysiology.Methods: Retrospective case review (short stature with chromosome 18 rearrangement), investigation for GH deficiency (peak GH <7 μg/l on glucagon or ITT, unless otherwise indicated) and determining response to GH treatment.Results: In 13 year six such cases were referred from the geneticists, mean ref...

ea0029oc17.3 | Diabetes Basic | ICEECE2012

Caerulin precursor fragment (CPF-AM1): a novel insulinotropic peptide from the skin secretion of the clawed frog, Xenopus amieti

Ojo O. , Conlon J. , Flatt P. , Abdel-Wahab Y.

We reported the isolation and structural characterization of CPF-AM1 and other peptides from the skin secretion of Xenopus amieti. This study investigated the insulin-releasing activities of synthetic CPF-AM1 using clonal pancreatic cell line, BRIN-BD11 and Swiss TO mice with diet-induced insulin resistance.Acute insulin-release studies were performed in Krebs Ringer bicarbonate buffer supplemented with 5.6 mM or 16.7 mM glucose, purified synthetic pepti...

ea0029p981 | Female Reproduction | ICEECE2012

Metabolic and hormonal parameters in lean PCOS women

Dolfing J. , van Haard P. , Schweitzer D. , Wolffenbuttel B.

Background: A minority of women with polycystic ovary syndrome (PCOS) is lean, and several individuals have no signs of hyperandrogenaemia. Earlier we showed that lean PCOS patients have no increased visceral adiposity. The aim of the present study was study is to characterize the metabolic and hormonal status a group of lean PCOS cases.Methods: In this cross-sectional study ten Caucasian women with PCOS and ten controls carefully matched for age and BMI...

ea0011oc49 | Calcium and bone OC49 Novartis Oncology Young Investigator Award | ECE2006

The A990G polymorphism of calcium sensing receptor gene (CASR) is associated with nephrolithiasis in patients with primary hyperparathyroidism (PHPT)

Eller-Vainicher C , Filopanti M , Vezzoli G , Soldati L , Saeli P , Beck-PEccoz P , Spada A , Corbetta S

Primary HPT shows a great variability in its clinical course and severity, which might be related to polymorphic variants of the CASR gene. The aim of the study was to evaluate the frequency of two known CASR single nucleotide polymorphisms (SNPs), i.e. G/T at codon 986 and G/A at codon 990, in a homogenous North-Italian cohort of PHPT patients compared with a sex and age matched healthy population and the possible correlation of these CASR gene variants with the clinical and ...

ea0007p104 | Endocrine tumours and neoplasia | BES2004

A somatostatin analogue and octreotide exert anti-proliferative effects on colonic cancer cells

Khalaf S , Bailey F , Davies D , Ogunkolade B , Kelly P , McCarthy K , Laban C , Bustin S , Jenkins P

Introduction: Somatostatin and its analogues (SSA) have been reported to have anti-proliferative effects. We have recently demonstrated expression of all 5 somatostatin receptor sub-types in normal and malignant colonic tissue. SOM-230 (Novartis) is a novel SSA that has a wider binding affinity to somatostatin receptors compared to octreotide (OCT). Its effects on proliferation of colonic cancer cells are unknown.Aims: To determine the effects of SOM-230...